The Prevalence of Lower Urinary Tract Symptoms (LUTS) in Poland

Overview

The first large population-based study to evaluate lower urinary tract symptoms (LUTS) in Poland. The study objective is to assess the prevalence and bother of LUTS in the population aged ≥40 years in Poland.

Full Title of Study: “The Prevalence of Lower Urinary Tract Symptoms (LUTS) in Poland: Epidemiology of LUTS (Poland LUTS) Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: December 31, 2019

Detailed Description

The first large population-based study to evaluate lower urinary tract symptoms (LUTS) in Poland. The study objective is to assess the prevalence and bother of LUTS in the population aged ≥40 years in Poland. This study will be conducted as a telephone survey with assessment of LUTS using a standardized protocol, which included the International Prostate Symptom Score (IPSS) and, for overactive bladder (OAB), the OAB-V8 questionnaire. Participants will be asked to rate how often they experienced individual LUTS and the degree of associated bother. The study will be performed in a representative group of Polish population (n = 6,000) covering all geographic regions of Poland (defined by the Central Statistical Office of Poland).

Interventions

  • Other: There will be no intervention
    • There will be no intervention

Clinical Trial Outcome Measures

Primary Measures

  • Prevalence of LUTS
    • Time Frame: Through study completion, an average of 3 months
    • The prevalence of LUTS will be assessed using definitions of the International Continence Society (descriptive statistics).
  • Symptom bother of LUTS
    • Time Frame: Through study completion, an average of 3 months
    • The degree of associated bother will be assessed using Likert scale (Likert scale: not at all [score 0], a little bit [score 1], somewhat [score 2], quite a bit [score 3], a great deal [score 4], or a very great deal [score 5]).

Secondary Measures

  • Prevalence of specific symptoms
    • Time Frame: Through study completion, an average of 3 months
    • The prevalence of specific symptoms will be assessed using a standardised protocol based on the definitions provided by the International Continence Society (i.e. storage symptoms, voiding symptoms and post-micturition symptoms) [Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167-178]. Participants will be asked to rate how often they experienced individual LUTS during the past month. A Likert scale will be used with the following options: none (score 0), <1 in 5 times (score 1), <half the time (score 2), about half the time (score 3), >half the time (score 4), or almost always (score 5).
  • Symptom bother of specific symptoms
    • Time Frame: Through study completion, an average of 3 months
    • The degree of associated bother of specific symptoms will be assessed using Likert scale (Likert scale: not at all [score 0], a little bit [score 1], somewhat [score 2], quite a bit [score 3], a great deal [score 4], or a very great deal [score 5]).
  • Prevalence of OAB
    • Time Frame: Through study completion, an average of 3 months
    • The prevalence of OAB will be assessed with the Overactive Bladder-Validated 8-question Screener (OAB-V8)questionnaire.

Participating in This Clinical Trial

Inclusion Criteria

Age >40 Exclusion Criteria:

Age <40 Pregnancy Urinary tract infection in the past 4 weeks

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Jagiellonian University
  • Collaborator
    • Piotr Chlosta
  • Provider of Information About this Clinical Study
    • Principal Investigator: Mikolaj Przydacz, Assistant – Jagiellonian University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.